[Some immunological criteria of the effectiveness of prodigiosan in the treatment of chronic cholecystitis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001646:Bile / Q000382:microbiology; D002764:Cholecystitis / Q000188:drug therapy* / Q000276:immunology*; D002908:Chronic Disease; D003165:Complement System Proteins; D006801:Humans; D009113:Muramidase / Q000097:blood; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011353:Prodigiosin / Q000627:therapeutic use; D012706:Serratia marcescens
D000900:Anti-Bacterial Agents; D011135:Polysaccharides, Bacterial; D003165:Complement System Proteins; D009113:Muramidase; D011353:Prodigiosin
Nekotorye immunologicheskie pokazateei effektivnosti prodigiozana pri khronicheskukh kholetsistitakh.